scPharmaceuticals Inc.
NASDAQ:SCPH
2.44 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -85.148 | -54.81 | -36.838 | -28.034 | -32.209 | -32.996 | -29.443 | -23.817 | -24.377 | -10.518 |
| Depreciation & Amortization
| 0.02 | 0.626 | 0.468 | 0.438 | 0.399 | 0.364 | 0.332 | 0.167 | 0.005 | 0.004 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0.03 | 0.002 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 5.442 | 4.856 | 2.838 | 2.366 | 2 | 1.449 | 2.135 | 0.947 | 0.876 | 0.379 |
| Change In Working Capital
| 0 | -6.321 | -0.35 | -2.599 | 1.448 | 0.354 | -2.21 | -0.177 | 1.529 | 0.889 |
| Accounts Receivables
| -7.289 | -4.489 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0.1 | -7.609 | -1.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.592 | 5.556 | 1.767 | -2.365 | 1.212 | 0.965 | -1.377 | 0.951 | 1.743 | 0.974 |
| Other Working Capital
| 0 | 0.221 | -0.887 | -0.234 | 0.236 | -0.611 | -0.833 | -1.128 | -0.214 | -0.085 |
| Other Non Cash Items
| 9.148 | -3.595 | -0.695 | 0.678 | 0.639 | 0.385 | 0.374 | 0.198 | 6.512 | -0.394 |
| Operating Cash Flow
| -70.538 | -59.244 | -34.577 | -27.151 | -27.693 | -30.442 | -28.812 | -22.682 | -15.455 | -9.64 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.021 | -0.04 | -0.021 | -0.009 | 0 | 0 | 0 | -0.194 | -0.009 | -0.017 |
| Acquisitions Net
| 0 | 0 | 45.838 | -32.139 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | -50.595 | -67.538 | -9.011 | -72.16 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 29.32 | 70.6 | 21.7 | 41.15 | 38.7 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | -45.838 | 32.139 | -33.46 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 29.299 | 19.965 | -45.859 | 32.13 | -33.46 | 0 | 0 | -0.194 | -0.009 | -0.017 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -3.228 | 0 | 29.801 | -2.5 | 0 | 9.555 | -0.062 | 9.273 | 12.6 | 0 |
| Common Stock Issued
| 53.547 | 14.038 | 47.765 | 0.051 | 60.576 | 3.973 | 0 | 92.71 | 40.639 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | -0.081 | -0.164 | 0 | -0.004 | -0.003 | 0 | -0.009 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 19.761 | 0.812 | -0.337 | -0.081 | -0.228 | 0.06 | 0.058 | 0.094 | 40.573 | 8.026 |
| Financing Cash Flow
| 70.08 | 14.85 | 77.229 | -2.53 | 60.348 | 13.588 | -0.008 | 102.074 | 53.173 | 8.017 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 28.841 | -24.429 | -3.207 | 2.449 | -0.805 | -16.854 | -28.82 | 79.198 | 37.709 | -1.64 |
| Cash At End Of Period
| 75.655 | 46.814 | 71.243 | 74.45 | 72.001 | 72.806 | 89.66 | 118.48 | 39.282 | 1.573 |